Idioma:

Human Telomerase Reverse Transcriptase (hTERT) Is a Novel Target of the Wnt/β-Catenin Pathway in Human Cancer

Zhang, Yong ; Toh, LingLing ; Lau, Peishan ; Wang, Xueying

The Journal of biological chemistry, 2012-09, Vol.287 (39), p.32494-32511 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por

Enviar para

Título:
Human Telomerase Reverse Transcriptase (hTERT) Is a Novel Target of the Wnt/β-Catenin Pathway in Human Cancer
Autor: Zhang, Yong ; Toh, LingLing ; Lau, Peishan ; Wang, Xueying
Assuntos: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics ; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism ; beta Catenin - genetics ; beta Catenin - metabolism ; Cancer Biology ; Carcinogenesis ; Cell Biology ; Cell Line, Tumor ; Gene Expression Regulation, Enzymologic ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Proteins - genetics ; Neoplasm Proteins - metabolism ; Neoplasms - genetics ; Neoplasms - metabolism ; Neoplasms - pathology ; Promoter Regions, Genetic - genetics ; Signaling ; Telomerase ; Telomerase - biosynthesis ; Telomerase - genetics ; Telomerase Regulation ; Telomere - genetics ; Telomere - metabolism ; Telomeres ; Transcription Factor 4 ; Transcription Factors - genetics ; Transcription Factors - metabolism ; Wnt Proteins - genetics ; Wnt Proteins - metabolism ; Wnt Signaling Pathway ; Wnt/beta-Catenin Pathway
É parte de: The Journal of biological chemistry, 2012-09, Vol.287 (39), p.32494-32511
Descrição: Telomerase activation plays a critical role in human carcinogenesis through the maintenance of telomeres, but the activation mechanism during carcinogenesis remains unclear. The human telomerase reverse transcriptase (hTERT) promoter has been shown to promote hTERT gene expression selectively in tumor cells but not in normal cells. Deregulation of the Wnt/β-catenin signaling pathway is reported to be associated with human carcinogenesis. However, little is known about whether the Wnt/β-catenin pathway is involved in activating hTERT transcription and inducing telomerase activity (TA). In this study, we report that hTERT is a novel target of the Wnt/β-catenin pathway. Transient activation of the Wnt/β-catenin pathway either by transfection of a constitutively active form of β-catenin or by LiCl or Wnt-3a conditioned medium treatment induced hTERT mRNA expression and elevated TA in different cell lines. Furthermore, we found that silencing endogenous β-catenin expression by β-catenin gene-specific shRNA effectively decreased hTERT expression, suppressed TA, and accelerated telomere shortening. Of the four members of the lymphoid-enhancing factor (LEF)/T-cell factor (TCF) family, only TCF4 showed more effective stimulation on the hTERT promoter. Ectopic expression of a dominant negative form of TCF4 inhibited hTERT expression in cancer cells. Through promoter mapping, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay, we found that hTERT is a direct target of β-catenin·TCF4-mediated transcription and that the TCF4 binding site at the hTERT promoter is critical for β-catenin·TCF4-dependent expression regulation. Given the pivotal role of telomerase in carcinogenesis, these results may offer insight into the regulation of telomerase in human cancer. Background: Telomerase up-regulation is found in about 90% of human cancer specimens and contributes actively to carcinogenesis. Results: β-Catenin·TCF4 plays an important role in telomerase activation. Conclusion:hTERT is a direct transcriptional target of the Wnt/β-catenin pathway. Significance: Identifying the function of the Wnt/β-catenin pathway in telomerase regulation provides better insight into the role of Wnt pathway in carcinogenesis.
Editor: United States: Elsevier Inc
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 3

Realização: Logos de Redes Sociais:

Human Telomerase Reverse Transcriptase (hTERT) Is a Novel Target of the Wnt/β-Catenin Pathway in Human Cancer

Zhang, Yong ; Toh, LingLing ; Lau, Peishan ; Wang, Xueying

United States: Elsevier Inc

Buscando em bases de dados remotas. Favor aguardar.